These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3034690)

  • 1. Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE.
    Norris PG; Schofield O; Dowd PM; Greaves MW
    Dermatologica; 1987; 174(5):219-23. PubMed ID: 3034690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.
    Dowd PM; Black AK; Woollard PW; Greaves MW
    Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
    Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
    Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
    Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
    Fogh K; Herlin T; Kragballe K
    J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
    Wong E; Camp RD; Greaves MW
    J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
    Kragballe K; Desjarlais L; Duell EA; Voorhees JJ
    J Invest Dermatol; 1986 Jul; 87(1):47-52. PubMed ID: 3088130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products.
    Cunningham FM; Wong E; Woollard PM; Greaves MW
    Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid is a more potent neutrophil chemoattractant than the 12(R) epimer in the rat cornea.
    Wiggins RE; Jafri MS; Proia AD
    Prostaglandins; 1990 Aug; 40(2):131-41. PubMed ID: 2171040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2.
    Ruzicka T; Burg G
    J Invest Dermatol; 1987 Feb; 88(2):120-3. PubMed ID: 3027188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation and degradation of leukotriene B4, 12-hydroxyeicosatetraenoic acid and 5-hydroxyeicosatetraenoic acid induced by ultraviolet radiation.
    Lehmann B; Kämpf A; Barth J
    Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):8-14. PubMed ID: 1327059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid.
    Bacon KB; Camp RD; Cunningham FM; Woollard PM
    Br J Pharmacol; 1988 Nov; 95(3):966-74. PubMed ID: 2850067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4).
    Fogh K; Hansen ES; Herlin T; Knudsen V; Henriksen TB; Ewald H; Bünger C; Kragballe K
    Prostaglandins; 1989 Feb; 37(2):213-28. PubMed ID: 2543035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro.
    Cunningham FM; Woollard PM
    Prostaglandins; 1987 Jul; 34(1):71-8. PubMed ID: 3317516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytes.
    Wainwright S; Falck JR; Yadagiri P; Powell WS
    Biochemistry; 1990 Oct; 29(43):10126-35. PubMed ID: 2176862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SC-41930 inhibits neutrophil infiltration of the cavine dermis induced by 12(R)-hydroxyeicosatetraenoic acid.
    Fretland DJ; Widomski DL; Shone RL; Penning TD; Miyashiro JM; Djuric SW
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):169-72. PubMed ID: 2560200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SC-41930, a leukotriene B4 receptor antagonist, inhibits 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding to epidermal cells.
    Kemény L; Ruzicka T
    Agents Actions; 1991 Mar; 32(3-4):339-42. PubMed ID: 1650525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activity of natural mono-, di- and tri-hydroxy derivatives of arachidonic acid on guinea-pig lungs: myotropic effect and stimulation of cyclooxygenase activity.
    Sirois P; Roy S; Beraldin G; Vallerand P; Borgeat P
    Prostaglandins; 1982 Sep; 24(3):405-18. PubMed ID: 6296925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions.
    Fogh K; Kiil J; Herlin T; Ternowitz T; Kragballe K
    Arch Dermatol Res; 1987; 279(8):504-11. PubMed ID: 2829753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.